Ethylene oxide residual analysis is performed to determine the remaining levels of ethylene oxide (EO) and its toxic by-products such as ethylene chlorohydrin (ECH) and ethylene glycol (EG) after sterilization of medical devices.
This procedure is defined in TS EN ISO 10993-7 Annex B, and it is mandatory for devices with patient contact.
Classified as carcinogenic and mutagenic (IARC Group 1).
Causes irritation on respiratory system, eyes, and skin.
Residual EO, ECH, or EG on medical devices can lead to serious toxicity in patients.
| Device Contact Type | EO Residual Limit (mg/day) | ECH Residual Limit (mg/day) |
|---|---|---|
| Short-term contact (<24 h) | ≤ 4 mg | ≤ 9 mg |
| Long-term contact (>24 h) | ≤ 2 mg | ≤ 4 mg |
| Implantable device | ≤ 0.1 mg | ≤ 0.5 mg |
Devices are aerated after sterilization.
Sample size determined based on surface area or volume.
Samples are extracted with suitable solvent in sealed vials.
Column: PEG / DB-Wax capillary
Detector: FID or Mass Spectrometry
Calibration using EO, ECH, EG standards
Ensures post-sterilization safety
Required for CE marking, FDA approval, and ISO 13485 compliance
Prevents toxic exposure in patients
Essential for sterilization validation and requalification
At TTS Laboratory Services, we offer EO residual analysis according to TS EN ISO 10993-7 Annex B using validated GC-FID / GC-MS methods.
EO, ECH, EG quantification
Sterilization validation support
Toxicological risk assessment
ISO/IEC 17025-compliant reporting